RT @maiti_86: https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
RT @maiti_86: https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
RT @maiti_86: https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
RT @maiti_86: https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
RT @maiti_86: https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
RT @maiti_86: https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
https://t.co/Yx1uYHFoQJ 中国の研究もう一つ。 https://t.co/mvXi3KrHjH
@hate_eyeNerds @lrakreyem @FiveTimesAugust Memes are expedient and succinct. I've no idea what you think I've "won." But you are talking shite 🤷♀️ https://t.co/U1uKogCsRe
@DrJuliePonesse I would not change anything. On 16/3/2020, this paper appeared in Nature Med Breadth of concomitant immune responses prior to patient recovery:a case report of non-severe C19 https://t.co/0HIHXXdToK Upon reading it, I knew I had no reas
@MikeDonio After reading this Nature paper dated 16 March 2020, like the 47-year old patient who fully recovered, I too have adequate #naturalimmunity against SARSCOV2: https://t.co/0HIHXXdToK
@SHomburg 1/x Mein Wendetag war in March 2020, als ich diese Nature paper 16.3.2020 las: „A 47-year-old woman from Wuhan…China…to emergency…in Melbourne 🇦🇺 … She was discharged … on day 11. Her symptoms resolved COMPLETELY by day 13…she remained well at da
Just leaving this here to see the amount of views it gets.
@OssiTiihonen @THLorg @THLresearch @Fimea Ohessa yksi tutkimus immuunivasteen nopeudesta toipuneella oireellisella potilaalla: https://t.co/KS0HAYlKDw
RT @SabinaWalker18: Q1 con‘t To reduce fear of virus, here is the original paper by Katherine Kedzierska et al dated 16/3/2020 https://t.…
RT @NatureMedicine: Breadth of concomitant immune responses prior to patient recovery: a case report of a non-severe #COVID19 @unimelb @…
RT @SabinaWalker18: 41.1/x The paper https://t.co/y1iUr7vlqK
Q1 con‘t To reduce fear of virus, here is the original paper by Katherine Kedzierska et al dated 16/3/2020 https://t.co/y1iUr7vlqK
41.1/x The paper https://t.co/y1iUr7vlqK
@howbeef Fear of what? I fear permanently losing democracy more than i fear the virus. I stopped fearing the virus when i read this science paper dated 16/3/2020: https://t.co/FsFQ880xAf By Prof Katherine Kedzierska et al: https://t.co/A8rljwR9Gw
RT @DilettanteMD: - Cytokine profile of a mild-moderate case of #COVID2019 A SNP in the IFN-induced transmembrane protein 3 gene could be…
RT @AndyBiotech: When it comes to #COVID19, we'll take all the encouraging data we can. Case report that non-severe patient does develop…
RT @lolaflo1972: VITAMIN C IS THE KEY 🔑 https://t.co/diHEDl93rE
@PredatorDiaries @iangtobin @bio_clouseau however, from the little evidence i've seen, peak CD4+ responses appear to be on the order of 1% of CD4+ cells, quite a bit higher than we see here. one data point is an early patient... https://t.co/MT0I6zTxrB htt
RT @davidasinclair: A flu-susceptibility variant (C/C) was found in the Interferon Induced Transmembrane Protein 3 gene (IFITM3). It will…
Maintaining our #immune system is critical. Researchers from Uni of Melbourne have outlined how immune system mounts its response to the new #coronavirus. “... a robust immune response across different cell types was associated with clinical recovery..”
@curexcomplex BTW, here is Prof #KatherineKedzierska et al wrt immune responses to #SARS_CoV_2. COVID-19: The immune system can fight back https://t.co/BMsCeHHZTY Breadth of concomitant immune responses prior to patient recovery: a case report of non-sev
@ProfKarolSikora Hi @ProfKarolSikora , Have you seen this paper that also mentioned T Cell involvement months ago ? https://t.co/FsFQ880xAf
RT @davidasinclair: A flu-susceptibility variant (C/C) was found in the Interferon Induced Transmembrane Protein 3 gene (IFITM3). It will…
RT @AlexanderDent6: "Increased antibody-secreting cells (ASCs), follicular helper T cells (TFH cells), activated CD4+ T cells & CD8+ T cell…
@DanielaMCastell @doctormosqueda Aquí te dejo más artículos y te invito a que investigues y leas de artículos científicos. https://t.co/h779pxXNqX y https://t.co/HWqTx2n0Kz
RT @kevinpurcell: SNP “rs12252-C/C in the gene IFITM3 (which encodes interferon-induced transmembrane protein 3) is linked to severe influe…
RT @NGL97230373: https://t.co/aPfOBWYxhl 1/ Full resolution of symptoms after viral infection subsided (> day 7). "The emergence and rap…
13. Yea, Vitamin C. Take it. Store it. Share it. Definitely during the fall and winter. https://t.co/U3fHaaGK4D All the best. Much love. 1 Thessalonians 5:21 N
RT @davidasinclair: A flu-susceptibility variant (C/C) was found in the Interferon Induced Transmembrane Protein 3 gene (IFITM3). It will…
RT @davidasinclair: A flu-susceptibility variant (C/C) was found in the Interferon Induced Transmembrane Protein 3 gene (IFITM3). It will…
#Plandemic2020 1/ Here's why #Hydroxychloroquine works. It's about the EARLY phase of #COVID__19, bc from all persons going into late phase only those with underlying condition shift towards severe symptoms in the LATE phase. https://t.co/U3fHaaGK4D h
@thierrybaudet Weet je wat ook nergens op slaat? Dat de Lancet zelf verwijst naar het gebruik van #VitamineC ter preventie van sepsis geïnduceerde cytokine storm gerelateerde ARDS symptomen. Want ja, het middel tegen bacteriële lekkage groeit gewoon wild.
@OJWANGJEF @PharmaFactz None taken. https://t.co/7w6c0IgltH
RT @NGL97230373: @va_shiva https://t.co/U3fHaaGK4D My take on #VitaminC VitaminC shifts the gut-liver-lung microbiotic axis tightening g…
@va_shiva https://t.co/U3fHaaGK4D My take on #VitaminC VitaminC shifts the gut-liver-lung microbiotic axis tightening gap junctions of the epithelial layer, decreasing membrane permeability and bacterial leakage, mitigating sepsis-induced cytokine storm
@cjtruth https://t.co/U3fHaaGK4D Wait until they destroy all Vitamin C factory plants, THEN, you really need to worry, as Vitamin C mimics Hydroxychloroquine by slowing down ferritin receptor degradation.
@John_F_Kennnedy #VitaminC imitates hydroxychloroquine https://t.co/U3fHaaYkWb
@LornaTaylor5 @Twitspice @CausticCorner @BBCFergusWalsh @johnsweeneyroar This one details an individual immune response in a "mild to moderate" case. https://t.co/Xssy0sNi8S
RT @kevinpurcell: SNP “rs12252-C/C in the gene IFITM3 (which encodes interferon-induced transmembrane protein 3) is linked to severe influe…
RT @thelonevirologi: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 https://t.co/…
Evidence of temporary immunity – https://t.co/uxa4wIrhG2 Coronaviruses are recognized by TLR7, RIG-I/MDA, and cGAS/STING innate immune sensors necessary for control of infection. https://t.co/F43XSq0Jdh
@earthma23 @Therese_Rein Genetics, clinical evidence of similar path to SARS and MERS. See: Prof. Andrew Taylor-Robinson, infectious disease immunology at CQU; + report on kinetics of immune responses re clinical/virological features of a patient with COVI
RT @AzzaGadir: Could the same CD8+ T cells recruited for anti-viral function drive KD-like symptoms due to a failure in immune-regulation a…
RT @AzzaGadir: This group presented evidence that CD8+ T cells, IgM and IgG antibodies bound to SARS-CoV-2 were detected in blood before sy…
Could the same CD8+ T cells recruited for anti-viral function drive KD-like symptoms due to a failure in immune-regulation after viral-clearance? 3/3
This group presented evidence that CD8+ T cells, IgM and IgG antibodies bound to SARS-CoV-2 were detected in blood before symptomatic recovery and are key for symptom-resolution 2/3: https://t.co/GbdV3Qn6od
RT @BioLegend: Understanding the immune response after SARS-CoV-2 infection is important to develop vaccines. See how Thevarajan et al. use…
Then we have direct evidence that Covid-19 elicits a range of immune responses in humans even in mild to moderate cases: https://t.co/OWEFIO2eMS — and antibody testing carried out in various places has returned significant seropositive rates. •7/21
RT @BioLegendJP: #SARSCoV2 感染による免疫応答を理解することは、ワクチンの開発に重要です。 Thevarajan et al. Nat Med 26, 453–455 (2020)では、#BioLegend の製品を用いて #COVID19 患者の免…
#SARSCoV2 感染による免疫応答を理解することは、ワクチンの開発に重要です。 Thevarajan et al. Nat Med 26, 453–455 (2020)では、#BioLegend の製品を用いて #COVID19 患者の免疫系細胞が調べられています。 詳細はこちら👇🏼 https://t.co/l7GZ8F3Qeb
To the scratchpad ... https://t.co/M1hyiWiS5p
Understanding the immune response after SARS-CoV-2 infection is important to develop vaccines. See how Thevarajan et al. used our reagents in a Nature correspondence article to identify immune cell populations in a patient with COVID-19: https://t.co/UwJvy
Understanding the immune response after SARS-CoV-2 infection is important to develop vaccines. See how Thevarajan et al. used our reagents in a Nature correspondence article to identify immune cell populations in a patient with COVID-19: https://t.co/r5z33
RT @toxiven_biotech: Can our immune system fight against COVID-19? For further information please visit: https://t.co/vv6UZ6cl5e #corona…
RT @analise_covid19: 7.Thevarajan, I., Nguyen, T., Koutsakos, M., Druce, J., Caly, L., & van de Sandt, C. et al. (2020). Nature Medicine,…
7.Thevarajan, I., Nguyen, T., Koutsakos, M., Druce, J., Caly, L., & van de Sandt, C. et al. (2020). Nature Medicine, 26(4), 453-455. doi: 10.1038/s41591-020-0819-2 https://t.co/BIqvk21KRi
@TheDohertyInst @jmcvernon 2/2 Thevarajan et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 26, 453–455 (16/3/2020). https://t.co/FsFQ880xAf
@nadelcap @vincevlo … Enfin, si on les a faits au début, chez les singes https://t.co/LjexVNfdEp puis chez l'homme https://t.co/SlvakBUnCT — et une fois que la règle est établie on s'intéresse aux exceptions. …
RT @gro_tsen: @Pfff__Encore_un Enfin, surtout parce que ces articles ont déjà été faits: https://t.co/SlvakBUnCT (chez l'homme) et https://…
@scr8_ @Konig_Deus @tonigarciaxx @MundoMaldini @navedelmisterio A esto me refiero con fuentes fiables. https://t.co/KQ8IMHZd1Z
@Pfff__Encore_un Enfin, surtout parce que ces articles ont déjà été faits: https://t.co/SlvakBUnCT (chez l'homme) et https://t.co/LjexVNfdEp (chez le singe).
@wabmester These are the numbers from a case study of a mild COVID-19 infection. https://t.co/HLKry4sFEp
"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19" https://t.co/ez2ZXbi18w
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. https://t.co/KFFhF2Tven
RT @SEinmunologia: (2/2) ¿Qué artículos se han usado para esta Parte 1? - ACE2, puerta de entrada: https://t.co/uIBxCZNipZ - "Secuestro" de…
RT @Alzhacker: https://t.co/IRJUJ9EExU SARS-Cov2は、SARS-Covと異なりウイルスがTリンパ球タイプの細胞にスパイクタンパク質を介して感染し侵入することができる。 SARS-Cov2は、CD147を利用してT細胞に侵入する。 C…
https://t.co/IRJUJ9EExU SARS-Cov2は、SARS-Covと異なりウイルスがTリンパ球タイプの細胞にスパイクタンパク質を介して感染し侵入することができる。 SARS-Cov2は、CD147を利用してT細胞に侵入する。 CD4とCD8が増加した患者での回復症例など。 https://t.co/ELEFpUVI5G
RT @SEinmunologia: (2/2) ¿Qué artículos se han usado para esta Parte 1? - ACE2, puerta de entrada: https://t.co/uIBxCZNipZ - "Secuestro" de…
RT @thelonevirologi: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 https://t.co/…
RT @thelonevirologi: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 https://t.co/…
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 https://t.co/uuHS2x0Wah
@Philouchi @lugdulu67 @gwendoSta allez quand on sait pas de quoi on parle on regarde dans un 1er temps les bonnes publications https://t.co/tPzH1HpQOg
RT @SEinmunologia: (2/2) ¿Qué artículos se han usado para esta Parte 1? - ACE2, puerta de entrada: https://t.co/uIBxCZNipZ - "Secuestro" de…
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 | Nature Medicine https://t.co/0Q19seVKHq
@RNAiAnalyst @DeadLiftCapital yes, and from this n=1 study of a COVID pt who recovered, the time course suggests that recovery was mediated by innate and CD8+ T cells; by the time plasma cells spike, viral load already gone https://t.co/dtOzfqd6nY
RT @mmw_lmw: #2020_ReCapMarch | a Case Report of #non_severe_COVID-19 | Breadth of concomitant immune responses prior to patient #Recovery…
RT @SEinmunologia: (2/2) ¿Qué artículos se han usado para esta Parte 1? - ACE2, puerta de entrada: https://t.co/uIBxCZNipZ - "Secuestro" de…
@mbalter @CyrilPedia @ScienceMagazine Hi Michael. Very different situation. #SARS_COV_2 is very highly conserved at the protein level (unlike HIV). Not a lot of evidence for immunity yet, but a) has been noted for SARS and MERS (need to find refs), b) http
RT @SEinmunologia: (2/2) ¿Qué artículos se han usado para esta Parte 1? - ACE2, puerta de entrada: https://t.co/uIBxCZNipZ - "Secuestro" de…